ID   604B1
AC   CVCL_DQ10
DR   GEO; GSM1040283
DR   GEO; GSM1040353
DR   Wikidata; Q54604318
RX   Patent=US20200407693;
RX   PubMed=22802639;
RX   PubMed=23193063;
RX   PubMed=24259714;
RX   PubMed=25665923;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*01:01,24:02; B*07:02,37:01; C*06:02,07:02; DQA1*01:01,03:03; DQB1*03:03,05:01; DRB1*01:01 (PubMed=30853558).
CC   Omics: Deep exome analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ08 ! 604A1
OI   CVCL_DQ09 ! 604A3
OI   CVCL_DQ32 ! 622C1
OI   CVCL_DQ15 ! 622E1
OI   CVCL_DQ16 ! 622G1
OI   CVCL_DQ30 ! 648A1
OI   CVCL_DQ17 ! 648B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 8
//
RX   Patent=US20200407693;
RA   Hotta A., Xu H.-G., Kaneko S., Wang B.;
RT   "Method for producing low-antigenic cell.";
RL   Patent number US20200407693, 31-Dec-2020.
//
RX   PubMed=22802639; DOI=10.1073/pnas.1209979109; PMCID=PMC3411998;
RA   Kajiwara M., Aoi T., Okita K., Takahashi R., Inoue H., Takayama N.,
RA   Endo H., Eto K., Toguchida J., Uemoto S., Yamanaka S.;
RT   "Donor-dependent variations in hepatic differentiation from
RT   human-induced pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12538-12543(2012).
//
RX   PubMed=23193063; DOI=10.1002/stem.1293;
RA   Okita K., Yamakawa T., Matsumura Y., Sato Y., Amano N., Watanabe A.,
RA   Goshima N., Yamanaka S.;
RT   "An efficient nonviral method to generate integration-free
RT   human-induced pluripotent stem cells from cord blood and peripheral
RT   blood cells.";
RL   Stem Cells 31:458-466(2013).
//
RX   PubMed=24259714; DOI=10.1073/pnas.1319061110; PMCID=PMC3870695;
RA   Koyanagi-Aoi M., Ohnuki M., Takahashi K., Okita K., Noma H.,
RA   Sawamura Y., Teramoto I., Narita M., Sato Y., Ichisaka T., Amano N.,
RA   Watanabe A., Morizane A., Yamada Y., Sato T., Takahashi J.,
RA   Yamanaka S.;
RT   "Differentiation-defective phenotypes revealed by large-scale analyses
RT   of human pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013).
//
RX   PubMed=25665923; DOI=10.1016/j.scr.2015.01.007;
RA   Toyoda T., Mae S.-i., Tanaka H., Kondo Y., Funato M., Hosokawa Y.,
RA   Sudo T., Kawaguchi Y., Osafune K.;
RT   "Cell aggregation optimizes the differentiation of human ESCs and
RT   iPSCs into pancreatic bud-like progenitor cells.";
RL   Stem Cell Res. 14:185-197(2015).
//
RX   PubMed=30853558; DOI=10.1016/j.stem.2019.02.005;
RA   Xu H.-G., Wang B., Ono M., Kagita A., Fujii K., Sasakawa N., Ueda T.,
RA   Gee P., Nishikawa M., Nomura M., Kitaoka F., Takahashi T., Okita K.,
RA   Yoshida Y., Kaneko S., Hotta A.;
RT   "Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with
RT   enhanced immune compatibility.";
RL   Cell Stem Cell 24:566-578.e7(2019).
//